Page 1 of 1

Earnings forecasts, valuations and ratings

Posted: Mon Feb 17, 2025 8:59 am
by Rina7RS
The company's early innovative products have also recently read out impressive clinical data: the Phase I clinical data of DLL ADC ZL for the treatment of small cell lung cancer read out excellent efficacy data on October , , further demonstrating the company's construction of independent research capabilities. It is expected that a dosefinding clinical study combining atezolizumab with platinum drugs as the firstline treatment for ESSCLC extensivestage small cell lung cancer and a phase I clinical study for other neuroendocrine tumors will be launched in .


CITIC Securities predicts that Zai Lab's operating revenue in will be US kuwait phone number list millionUS millionUS million, respectively, a yearonyear increase of .%.%.%; and its net profit attributable to shareholders will be US million millionUS million, respectively.

The bank used the absolute valuation method DCF to obtain the company's reasonable market value of HK. billion to HK. billion; and used the relative valuation method PS to obtain the company's reasonable equity value of HK. billion. In summary, referring to the relative valuation and absolute valuation, the company's corresponding target price in is calculated to be HK. For the first coverage, it is given a "buy" rating.
Guangzhou fired a shot


The house has been demolished and the temporary relocation allowance has stopped. What should I do?